Search Results

You searched for : GLP

	HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 ... Oct 29
	udChalo Announces Appointment of Shivam Arren as New CEO I look forward to building on the company's strong foundation, leading it into a new era of growth and service excellence, and working with ... Aug 01
	Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day Many weight management solutions available today ultimately fail – partly because patients do not receive the help they need, when they need it.... Jun 20
	Latest Research Highlights The Role of Liver Glucose Production in Type 2 Diabetes Continued research and advancements in understanding diabetes mechanisms will lead the way for more effective treatments and better health outcomes for millions worldwide.... Jun 08
	HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress Berberine Ursodeoxycholate (HTD1801) Provides a Unique Therapeutic Approach for Patients with Metabolic Liver Disease and Severe Insulin Resistance... Jun 05
	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
	Sanofi’s diabetes drug Soliqua® now available in India A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
	Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression The potential of repurposing existing medications, such as lixisenatide, to target Parkinson’s disease progression represents a significant stride forward in neurological research.... Apr 05
	Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability Dr. Paul highlighted that the generic sector of pharmaceutical companies currently holds a substantial portion of the Indian pharmaceutical market, exhibiting a growth rate approximately ... Jan 27
	FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
	Pills or Insulin â€“ Which works best for diabetes management? Of the various factors that contribute to diabetes, a sedentary lifestyle and improper intake of food constitute the major ones. Thus, along with drugs, insulin, ... Jan 04
	BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd. ... Mar 16
	Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
	I2O Therapeutics receives strategic investment from Colorcon Ventures Colorcon will collaborate with i2O to accelerate i2Oâ€™s research and development efforts... Dec 04
	Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation The MoU will help in establishing a framework for fruitful cooperation and exchange of information between the Central Drugs Standard Control Organization (CDSCO) and the ... Nov 04
	Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million... Oct 29
	GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050 GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
	Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH Brink Bilogics licenses bioanalytical testing solution to Fresenius Kabi SwissBioSim GmbH... Sep 11
	Potential therapeutics for COVID-19 should be tested for auditory safety The class of drugs used in covid treatment may result in loss of auditory senses... Sep 07
	Best Foods to Control Blood Sugars Studies have proved thatÂ cinnamon can bring down glucose levels and improve insulin affectability, but you should restrict your admission of cinnamon to under 1 ... Sep 03
	Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ... Aug 12
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
	Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 ... Sep 13
	Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA Aptorum Group Limited (Nasdaq: APM) (â€œAptorum Groupâ€), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ... Sep 12
25 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024

udChalo Announces Appointment of Shivam Arren as New CEO

Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day

Latest Research Highlights The Role of Liver Glucose Production in Type 2 Diabetes

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India

Sanofi’s diabetes drug Soliqua® now available in India

Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development

Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression

Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

Pills or Insulin â€“ Which works best for diabetes management?

BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd.

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment

I2O Therapeutics receives strategic investment from Colorcon Ventures

Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation

Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050

Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH

Potential therapeutics for COVID-19 should be tested for auditory safety

Best Foods to Control Blood Sugars

Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

Trending Now